Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -82.32% | -146.02% | -212.83% | 14.11% | 71.61% |
| Total Depreciation and Amortization | -24.40% | -21.28% | -18.71% | -4.06% | 15.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -139.83% | -94.97% | 107.88% | 4,314.77% | 635.75% |
| Change in Net Operating Assets | 124.22% | 124.22% | 124.22% | -93.20% | -258.68% |
| Cash from Operations | 2.97% | 6.23% | 9.20% | 25.33% | 37.72% |
| Capital Expenditure | -168.68% | -58.33% | -7.34% | 20.94% | 50.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 75.36% | 91.52% | 94.87% | 85.02% | 70.62% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.72% | -102.85% | -101.47% | -101.17% | -100.83% |
| Cash from Investing | 66.86% | 33.94% | -215.70% | -383.45% | -256.73% |
| Total Debt Issued | -73.22% | -29.13% | 86.53% | 232.90% | 653.00% |
| Total Debt Repaid | 68.78% | 69.78% | 70.70% | 21.08% | -70.02% |
| Issuance of Common Stock | 54.29% | -17.10% | -42.31% | -44.61% | -48.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -80.66% | 10.60% | 39.89% | 45.78% | 54.18% |
| Cash from Financing | -6.85% | -7.50% | -8.51% | -2.58% | 8.32% |
| Foreign Exchange rate Adjustments | 526.95% | 711.21% | 1,168.18% | 554.24% | -221.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.72% | 270.52% | -11.60% | 85.14% | 66.01% |